Human GPR124 / TEM5 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Human GPR124 / TEM5 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHuman GPR124 / TEM5
Clonepolyclonal
Host SpeciesRabbit
Reactive SpeciesGibbon, human. predicted reactivity: monkey (at least 90% immunogen sequence identity)
Isotypen/a
Formatimmunoaffinity purified
Size0.05 mg
Concentration1 mg/ml
ApplicationsImmunohistochemistry (IHC - Paraffin)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSpecificity: Human GPR124. BLAST analysis of the peptide immunogen showed no homology with other human proteins. Tumor endothelial marker 5 is an Orphan-U GPCR with an unknown ligand. Tumor Endothelial Marker 5, like GPR125, has a leucine rich repeat (LRR), an immunoglobulin (Ig) domain, and a hormone-binding domain (HBD). The Ig domain shows similarities to motilin and titin, while the LRR domain shows similarities to LRIG1 and SLIT1-2.
ImmunogenImmunogen Description: Synthetic 19 amino acid peptide from N-terminal extracellular domain of human GPR124. Percent identity with other species by BLAST analysis: Human, Gibbon (100%); Monkey, Marmoset, Elephant (95%); Gorilla, Dog, Panda (89%); Bat, Hamster, Horse, Pig (84%).
Other Names[GPR124 / TEM5 (N-Terminus) IHC-plus; GPR124; G protein-coupled receptor 124; G-protein coupled receptor 124; TEM5; KIAA1531; Tumor endothelial marker 5; Human GPR124; TEM5], [TEM5]
Gene, Accession #[GPR124], Gene ID: 25960, NCBI: NP_116166.7, UniProt: Q96PE1
Catalog #MBS243888
Price$530
Order / More InfoHuman GPR124 / TEM5 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.